Cureus pembrolizumab-induced colitis and diarrhea in the treatment of sporadic colorectal cancer: a case report Pembrolizumab is an immune checkpoint that blocks programmed cell death receptor-1 (PD-1), a mainstay of cancer treatment. Inhibitor (ICI)…15 hours ago
Colorectal Cancer
Cureus pembrolizumab-induced colitis and diarrhea in the treatment of sporadic colorectal cancer: a case report Pembrolizumab is an immune checkpoint that blocks programmed cell death receptor-1 (PD-1), a mainstay of cancer treatment. Inhibitor (ICI)…15 hours ago
Cureus pembrolizumab-induced colitis and diarrhea in the treatment of sporadic colorectal cancer: a case report Pembrolizumab is an immune checkpoint that blocks programmed cell death receptor-1 (PD-1), a mainstay of…
📅 Published: January 24, 2024
👨⚕️ By: Nisha
Article Information & Medical Note
This article provides general educational information published on January 24, 2024 by Nisha. It is not a substitute for individual medical advice.